JDP Global latest news on UK Business
Click here for the latest health news
Egg shares inflates with speculation

Written by JDPGlobal | Wednesday, 20 July 2005

Online financial company Egg, mainly owned by the British insurer Prudential, has manages to add more than £57m to its market value and has attributed it  to pure speculation.  It comes as many believe that Citigroup, the American Investment bank is preparing a take-over.

It originally set its price too high with a sale tag of £1.5bn, leading it to find no buyer but it appears now that with a new chief executive appointed to Prudential, there comes the speculation for revival plans to sell Egg.

This sale also helps to relax the attitude of the shareholders who were infuriated by Pru's controversial £1bn rights issue, this is due to the fact that the cash should now be returned to investors when the sale occurs.  As an employer of about 2,000 people in the UK alone and with its profits  accounting to about £5m in the first quarter alone, there would need to be a major facelift within the company.

Shares in Egg speculatively closed 8.5p up at 113.75p at the London Stock Exchange.

© 2012 This content has been exclusively written by JDP Global


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
:: E-commerce project management on international platforms
:: Bringing new and exciting products to the market
:: International business growth
:: Bringing great products to the International market
 
 JDP Updates - case study - 2005 (e-commerce)

Overview
Some of our most challenging projects include sensitive data sites where sound legal advice is a constant, the UK Medix site and the UK Medix plus have been our toughest to date.
Providing online healthcare for patients suffering from Impotence, Obesity and Hairloss. UK Medix has developed into a popular UK Health clinic.
Developing the brand
To compliment UK Medix, we launched UK Medix Plus which includes extra features; forums, daily health tips, an online shopping cart system and a membership based option.
Summary so far
This is a complex platform, enabling qualified UK doctors to communicate with patients and our licensed pharmacists.  Treatments include tamiflu, acomplia, viagra, cialis, levitra, xenical, reductil, uprima & propecia

 

sitemap: home | contact us | about us | portfolio | e-commerce | legal advice | processing | marketing | international trade | login

associated: UK Medix | UK Medix Plus | UK Medix Plus Forum